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Abstract
Objective—Describe practice variations in ventilator strategies used for lung rest during 
extracorporeal membrane oxygenation (ECMO) for respiratory failure in neonates, and assess the 
potential impact of various lung rest strategies on the duration of ECMO and the duration of 
mechanical ventilation after decannulation.
Data Source—Retrospective cohort analysis from the extracorporeal life support organization 
(ELSO) registry database during the years 2008–2013.
Study selection—All ECMO runs for infants ≤ 30 days of life for pulmonary reasons were 
included.
Data extraction—Ventilator type and ventilator settings used for lung rest at 24 hours after 
ECMO initiation were obtained.
Results—A total of 3,040 cases met inclusion criteria. Conventional mechanical ventilation 
(CMV) was used for lung rest in 88% of cases and high frequency ventilation (HFV) was used in 
Address all correspondence to: Deepthi Alapati, MD, Address: Nemours, Alfred I. duPont Hospital for Children, Division of 
Neonatology, 1600 Rockland Road, Wilmington, DE 19803, Tel: 302 494 0552, Fax: 302 651 5458, Deepthi.alapati@nemours.org. 
Copyright form disclosures: Dr. Alapati received support for article research from the National Institutes of Health (NIH) and 
Extracorporeal Life Support Organization (ELSO); her institution received grant support from ELSO (study was funded by ELSO 
research grant) and from Delaware-CTR (research grant). Dr. Aghai’s institution received grant support from ELSO. Dr. Dirnberger 
received support for article research from ELSO, and his institution received grant support from ELSO and from Delaware - CTR 
(research grant). Dr. Ogino is employed by King Faisal Specialist Hospital, and he and his institution consulted for Hamad Medical 
Corporation; he received support for travel from Latin America ELSO, Asia Pacific ELSO, Queen Mary Hospital (Hong Kong), 
Society of Critical Care Medicine, and Unidad de Cuidados Intensivos Le Piete. Dr. Shaffer’s institution received grant support, and he 
received support for article research from the NIH, ELSO Grant, and P30 GM114736 COBRE. Dr. Hossain disclosed that he does not 
have any potential conflicts of interest.
HHS Public Access
Author manuscript
Pediatr Crit Care Med. Author manuscript; available in PMC 2018 July 01.
Published in final edited form as:
Pediatr Crit Care Med. 2017 July ; 18(7): 667–674. doi:10.1097/PCC.0000000000001171.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
12%. In the CMV group, 32% used positive end expiratory pressure (PEEP) strategy of 4–6 cm 
H2O (low), 22% used 7–9 cm H2O (mid) and 43% used 10–12 cm H2O (high). HFV was 
associated with an increased mean (SEM) hours of ECMO [150.2 (0.05) vs. 125 (0.02); p < 0.001] 
and an increased mean (SEM) hours of mechanical ventilation after decannulation [135 (0.09) vs. 
100.2 (0.03); p = 0.002], compared with CMV among survivors. Within the CMV group, use of 
higher PEEP was associated with a decreased mean (SEM) hours of ECMO [high vs. low: 136 
(1.06) vs. 156 (1.06), p = 0.001; mid vs. low: 141 (1.06) vs. 156 (1.06); p = 0.04] but increased 
duration of mechanical ventilation after decannulation in the high PEEP group compared with low 
PEEP (p= 0.04) among survivors.
Conclusions—Wide practice variation exists with regard to ventilator settings used for lung rest 
during neonatal respiratory ECMO. Use of HFV as compared to CMV and use of low PEEP 
strategy as compared to mid PEEP and high PEEP strategy is associated with longer duration of 
ECMO. Further research to provide evidence to drive optimization of pulmonary management 
during neonatal respiratory ECMO is warranted.
Keywords
Neonatal ECMO; lung rest; ELSO; respiratory failure; ventilator strategies; practice variations
INTRODUCTION
Severe respiratory failure in neonates that is unresponsive to conventional therapies is treated 
with extracorporeal membrane oxygenation (ECMO) to allow time for intrinsic recovery of 
the lungs (1–4). Although advances in conventional therapies have enabled a decline in the 
need for ECMO in recent years, respiratory failure remains the most common indication for 
ECMO among neonates, accounting for approximately 800 ECMO runs per year (5–7). 
These infants are at high risk of mortality and long-term respiratory and neurologic 
morbidities, and ongoing research is warranted to optimize pulmonary management and 
improve outcomes (2, 8–11).
Diffuse atelectasis and pulmonary inflammation induced by lowering mechanical ventilation 
and complement activation resulting from contact of blood with the foreign surfaces of the 
ECMO circuit in the 24-hour period following initiation of ECMO likely contribute to 
radiographic opacification of the lung fields (12, 13). In neonatal respiratory failure, ECMO 
provides the opportunity to decrease exposure to positive pressure ventilation and oxygen-
induced lung injury. Therefore, mechanical ventilator settings are significantly decreased 
following initiation of extracorporeal support to minimize ventilator-induced lung injury and 
promote healing. However, controversy exists regarding how much “rest” is ideal, and 
various strategies have been described. Although a minimal positive end expiratory pressure 
(PEEP) of 5 cm H2O has been applied historically to keep the lungs inflated above 
functional residual capacity, some centers advocate using a higher PEEP of 10–14 cm H2O 
to maintain alveolar recruitment and stability. In a randomized controlled trial, an open lung 
strategy with high PEEP of 12–14 cm H2O decreased the average duration of venoarterial 
(VA) ECMO by 34 hours in neonates (14). However, the effects of high PEEP on lung 
inflammation and lung injury remain unclear; hence, some centers continue to use a low 
PEEP strategy for lung rest. We hypothesized that practice variations exist in choice of lung 
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rest strategies during neonatal respiratory ECMO and that these variations may be associated 
with differences in short-term clinical outcomes.
The objectives of this study were to describe the ventilation practices for neonates who 
underwent extracorporeal life support (ECLS) for severe respiratory failure and to assess the 
potential impact of various lung rest strategies on the duration of ECMO and duration of 
mechanical ventilation after decannulation among survivors.
METHODS
The Extracorporeal Life Support Organization (ELSO) is an international consortium that 
maintains a registry of ECMO runs from its participating centers. Data from the ELSO 
registry database on 7,786 neonatal ECMO runs during the years 2008 to 2013 were 
analyzed. All ECMO runs that were initiated at less than or equal to 30 days of life for 
pulmonary indications, and for which data regarding mechanical ventilator settings at 24 
hours after ECMO initiation were available, were included in the study. Infants with 
congenital diaphragmatic hernia and those who underwent cardiac ECMO or extracorporeal 
cardiopulmonary resuscitation were excluded from the study. We obtained demographic, 
clinical, and ventilator setting data at 24 hours after initiation of ECMO, as well as outcomes 
data regarding mortality, duration of ECMO, and duration of mechanical ventilation after 
decannulation in all patients and in survivors. The incidence of various ventilator types used 
and ventilator settings were determined first. The two most common ventilator types and 
ventilator strategies were then used as comparison groups to analyze outcomes.
We summarized demographic and pre-ECMO characteristics in the overall population and 
within groups of interest. We examined differences in gestational age, postnatal age, birth 
weight, APGAR score, and underlying primary diagnosis between groups. Pre-ECMO 
characteristics, such as oxygenation index (OI), respiratory severity score (RSS), ventilator 
type, duration of mechanical ventilation, pH, and mean arterial blood pressure (MBP) just 
prior to initiation of ECMO, were analyzed. We also assessed ECMO pump flow 
requirements at 24 hours after initiation of ECMO and the mode of ECLS used, namely 
venovenous (VV), VA or a combination of VV and VA. All data were obtained in a de-
identified manner from ELSO and the protocol was exempt from full review by the 
Institutional Review Board at the Nemours/Alfred I. duPont Hospital for Children.
Statistical Analyses
Categorical variables were summarized as count and percentages, and continuous variables 
were expressed as median and interquartile ranges (IQR). Both graphic and numeric 
methods were used to examine the deviation from normality and other model assumptions. 
Suitable transformations were taken when needed. Two-sample t-tests or Mann-Whitney U-
tests for continuous variables, and Chi-square or Fisher’s exact test for categorical variables, 
whichever appropriate, were used to examine the distribution between group variables of 
interest. We examined the association between ventilator type and ventilator settings on the 
natural log transformed duration of ECMO and duration of mechanical ventilation after 
decannulation among survivors using an analysis of co-variance (ANCOVA) model. The 
ANCOVA models were adjusted for pre-specified confounding variables that were known to 
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be independently correlated with duration of ECMO and duration of mechanical ventilation 
after decannulation among survivors. The variables included in the model were gestational 
age, birth weight, age at time of initiation of ECMO, APGAR score of less than 5 at 5 
minutes, duration of mechanical ventilation prior to ECMO initiation, RSS, OI, pH, MBP, 
ECMO pump flow at 24 hours after ECMO initiation, and ECMO mode. Additionally, we 
generated ordinal categorical variables using the median splits of the duration of ECMO and 
duration of mechanical ventilation after decannulation and performed a multivariable 
logistic regression to further examine the association of these two variables with ventilator 
type and ventilator settings. The same variables that were used in the ANCOVA model were 
used in the multivariable logistic regressions. Adjusted odds ratios (AOR) with the 95% 
confidence interval (CI) were presented. Multiple imputation of ten repetitions was 
performed to account for missing data. Finally, subgroup analysis was performed among 
infants who received VA or VV modes of ECMO. All tests were two-tailed with the level of 
significance of 0.05. The statistical software SPSS, version 22 (IBM Corporation, Armonk, 
NY), was used for the data analysis.
RESULTS
Of the 7,786 neonatal ECMO runs between the years 2008 and 2013, we identified 3,272 
cases meeting inclusion criteria. Data regarding the ventilator type at 24 hours of ECLS 
were missing in 232 cases, and a total of 3,040 cases were included in the final analysis. 
Conventional mechanical ventilation (CMV) was used in 2,677 cases (88%), and high 
frequency ventilation (HFV) was used in 363 cases (12%) for lung rest. Within the CMV 
group, ventilator settings at 24 hours after ECMO initiation were analyzed to determine the 
most commonly used ventilator settings as shown in Table 1. Data regarding PEEP at 24 
hours after ECMO initiation were available in 2,659 cases. We found that 31.6% (841/2,659) 
used a low PEEP range of 4–6 cm H2O, 42.9% (1,142/2,659) used a high PEEP range of 10–
12 cm H2O, and 21.6% (574/2,659) used a mid-PEEP range of 7–9 cm H2O. Most 
practitioners who used CMV for lung rest used a rate of 10 cycles per minute and peak 
inspiratory pressure of 15–20 cm H2O. Fraction of inspired oxygen most commonly used at 
24 hours ranged from 0.21 to 0.40.
Comparison of HFV and CMV Groups
Demographics and clinical characteristics—First we compared differences between 
the HFV and CMV groups. We investigated whether differences in the demographic and pre-
ECMO characteristics were associated with the choice of HFV or CMV. Infants in the HFV 
group were less frequently ventilated with conventional mechanical ventilation prior to 
initiation of ECMO, had lower pH, higher RSS, higher OI, lower MBP prior to ECMO 
initiation, and were less frequently placed on VV ECMO compared with the CMV group as 
shown in table 2. Gestational age, birth weight, gender, low 5-minute Apgar score, postnatal 
age, duration of mechanical ventilation prior to ECMO initiation, and ECMO pump flow at 
24 hours after ECMO initiation were similar between the two groups (Table 2). The 
distribution of primary diagnoses that led to respiratory failure and ECLS was also similar 
between the two groups. The median (IQR) mean airway pressure at 24 hours after ECMO 
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initiation was 14 (12, 16) cm H2O in the HFV group and 10 (8, 12) cm H2O in the CMV 
group (p < 0.001).
Outcomes—Seventy-one percent (259/363) of infants in the HFV group were discharged 
alive from the ECMO center as compared with 78% (2,095/2,677) survival in the CMV 
group with an odds ratio (95% CI) of 0.69 (0.54 – 0.88); p = 0.03. However, there was no 
difference in survival after adjusting for the previously described confounding variables in 
the logistic regression. The adjusted odds ratio (95% CI) was 0.71 (0.47–1.09); p = 0.116. 
Among those who survived, infants in the HFV group required a greater duration of ECMO 
and greater duration of mechanical ventilation after decannulation compared with the CMV 
group after adjusting for the previously described confounding variables in the ANCOVA 
model (Table 3). The proportion of survivors who required more than median duration of 
ECMO was significantly higher in the HFV group compared with the CMV group, AOR 
(95% CI) of 1.52 (1.02, 2.3). The proportion of survivors who required more than median 
duration of mechanical ventilation after decannulation was significantly higher in the HFV 
group compared with the CMV group, AOR (95% CI) of 1.9 (1.23, 2.92) (Table 3). There 
was no substantial difference in the conclusions when multiple imputation of ten repetitions 
was performed to account for missing data.
When analyzed within subgroup of patients who received VA or VV ECMO modes, duration 
of ECMO and duration of mechanical ventilation was shorter in CMV group compared to 
HFV group (p < 0.05) in the subgroup of infants who received VA ECMO. In the subgroup 
of patients who received VV ECMO, duration of ECMO was shorter in the CMV group 
compared to HFV group (p=0.04), but there was no difference in the duration of mechanical 
ventilation after decannulation.
Complications—A greater proportion of infants in the HFV group had central nervous 
system (CNS) and pulmonary complications. Of these infants, 8.8% in the HFV group had 
pneumothorax during ECMO and required treatment, compared with 3.7% of infants in the 
CMV group (p < 0.05) (figure 1). A greater proportion of infants in the HFV group were 
diagnosed to have clinically determined seizures, though there were no differences in 
electroencephalographically-determined seizures. There were no differences between the 
groups in the incidence of CNS hemorrhage or infarct determined by ultrasound or 
computed tomography (CT).
Comparison of Low, Mid and High PEEP Groups
Demographics and clinical characteristics—We next compared outcomes between 
the low PEEP, mid PEEP and high PEEP groups. Infants in the high PEEP group had higher 
birth weights, lower 5 minute APGAR scores, higher RSS, higher mean blood pressure prior 
to ECMO initiation, and received conventional mechanical ventilation less frequently prior 
to ECMO initiation. A greater proportion of infants in the mid PEEP group received VV 
ECMO, as shown in table 4. Gestational age, gender, age at time of ECMO initiation, 
duration of mechanical ventilation prior to ECMO initiation, pH, OI and pump flow at 24 
hours after ECMO initiation were similar between the three groups (Table 4). A greater 
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proportion of infants in the high PEEP group were diagnosed with meconium aspiration 
syndrome compared with the low PEEP group [452 (39.7%) vs. 268 (32.1%); p < 0.001].
Outcomes—There was no difference in survival among the high PEEP, mid PEEP and low 
PEEP groups. Among survivors, infants in the high PEEP group required the shortest mean 
(standard error of mean) duration of ECMO compared with mid and low PEEP groups [136 
(1.06) hours vs. 141 (1.06) vs. 156 (1.06) hours, p = 0.004] after adjusting for the previously 
defined confounding variables in the ANCOVA model. The proportion of infants who 
required greater than median duration of ECMO was significantly lower in the high PEEP 
group compared with the low PEEP group, AOR (95% CI): 0.47 (0.3, 0.7) and significantly 
lower in the mid PEEP group compared with the low PEEP group, AOR (95% CI): 0.61 
(0.4, 0.9). Duration of ECMO was similar between the mid PEEP and high PEEP groups. 
There was no significant difference in the duration of mechanical ventilation after 
decannulation among the high, mid, and low PEEP groups (Table 5). When multiple 
imputation of ten repetitions was performed to account for missing data, the effect on 
ECMO hours was similar, but with marginally longer duration of mechanical ventilation in 
the high PEEP group compared to low PEEP after decannulation (p = 0.04). In the subgroup 
analysis, high PEEP group had shorter duration of ECMO compared to low PEEP group 
within the subgroup of patients who received VA ECMO (p=0.01), but there was no 
significant difference within the VV ECMO mode subgroup. There was no difference in the 
duration of mechanical ventilation after decannulation between the low, mid and high PEEP 
group among both the VV and VA ECMO mode subgroups.
Complications—There were no significant differences between the high PEEP and low 
PEEP groups with respect to the incidence of pneumothorax requiring treatment or CNS 
complications (figure 2).
DISCUSSION
This study demonstrates that there are wide practice variations in the use of lung rest 
ventilator settings during ECMO for neonatal respiratory failure among survivors. High 
frequency ventilation during the first 24 hours after ECMO initiation was independently 
associated with longer duration of ECMO and a longer duration of mechanical ventilation 
after decannulation compared with conventional mechanical ventilation in survivors. The use 
of high and mid PEEP levels during the first 24 hours of ECMO was independently 
associated with a shorter duration of ECMO but increase in duration of mechanical 
ventilation after decannulation in the high PEEP group compared with the low PEEP levels 
among survivors.
In neonates with severe respiratory failure, ECMO supports gas exchange and significantly 
decreases ventilator induced lung injury (VILI) by allowing for a decrease in the intensity of 
mechanical ventilation while optimizing recuperative tissue oxygenation (4). However, 
optimal ventilation strategies that minimize VILI while on ECMO remain unclear. 
Optimizing ventilator strategies to mitigate VILI may better facilitate lung healing, shorten 
the duration of ECMO and mechanical ventilation, and improve outcomes. The only 
randomized trial comparing different ventilator strategies during ECMO was performed 
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more than two decades ago at a time when VA bypass was by far the predominant mode of 
ECMO used for neonatal respiratory failure. In that study, the use of higher PEEP (12–14 
cm H2O) decreased the duration of ECMO by an average of 34 hours compared with a low 
PEEP (4–6 cm H2O) strategy (14). However, VA ECMO is used less commonly in recent 
years as compared to two decades ago, and severe neonatal respiratory failure is increasingly 
treated with VV ECMO, which is dependent upon blood flow through the lungs and 
adequate cardiac function. An optimal ventilator strategy during VV ECMO is unknown. In 
the absence of published comparison data, practices are often guided by clinical experience. 
Therefore, purpose of this study was to characterize the variations in ventilator strategies 
used to achieve lung rest during ECMO for neonatal respiratory failure and evaluate the 
potential associations between commonly used ventilator strategies and ECMO-related 
outcomes. We chose to evaluate outcomes from the years 2008 to 2013, which represent a 
recent cohort during which time most ECMO centers are likely to have adopted advanced 
ECLS technologies. We evaluated the duration of ECMO and the duration of mechanical 
ventilation after decannulation among survivors as clinical indicators of lung recovery. Data 
regarding total days of supplementation oxygen, a better indicator of lung disease, were not 
available in the database.
Clinical practice varies with regard to the timing of decannulation. Some clinicians prefer to 
continue ECMO support until lung recovery is nearly complete and the infant requires 
minimal ventilator support; whereas others prefer to decannulate sooner when the infant still 
requires moderately high ventilator support and a longer period of mechanical ventilation 
after ECMO. We therefore assessed the impact of rest ventilator strategies on both the 
duration of ECMO and the duration of mechanical ventilation after decannulation.
Infants who were managed with HFV during ECMO had higher pre-ECMO RSS, higher OI, 
lower pH, and lower mean blood pressure than infants managed with CMV, and they were 
sicker. However, after adjusting for confounding variables, there was no difference in 
survival to discharge between HFV and CMV groups. Our retrospective review did not 
enable us to pair individuals by illness severity. In this retrospective analysis, it is not 
possible to attribute causality to the use of HFV, and the finding that the HFV group required 
longer ECMO runs and longer post-ECMO ventilator duration may very arguably be 
attributable to greater severity of respiratory disease. Similarly, the higher incidence of 
pneumothorax in the HFV group may represent selection bias in the use of HFV to manage 
air leak. Due to the relatively small sample size of the HFV group (n=363) compared with 
the CMV group (2,767), we did not stratify the HFV group further into high vs. low mean 
airway pressure groups. Just as there were outcome differences between high PEEP and low 
PEEP strategies, it may be that specific HFV management strategies may impact the rates of 
survival, pulmonary and CNS complications, and post-ECMO respiratory recovery. Thus, 
the use of HFV during ECMO and specific HFV management strategies, warrants further 
prospective clinical investigation.
Our finding that a high PEEP strategy was associated with decreased ECMO duration is 
similar to Keszler et al.’s previous findings among VA ECMO patients, which were that 
infants managed with higher PEEP had shorter ECMO duration but similar time to 
extubation (14).
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Our study is the first to describe lung rest strategies in neonatal respiratory ECMO in a 
recent and large international dataset. We observed that mechanical ventilator settings used 
for lung rest varied significantly in spite of minimal differences in pre-ECMO clinical 
characteristics. These differences are likely the result of individual physician and center 
empiric practices. However, recent data indicate that decreasing center-to-center variability 
by employing evidence-based standardized practices can improve mortality and morbidity 
and reduce costs (15–17). Future prospective studies to identify optimal lung rest strategies 
therefore are needed to inform the development of evidence-based guidelines.
The limitations of this study include the retrospective nature of the study and bias associated 
with the accuracy of data entry. We were also unable to adjust for center variation, center 
level of experience or type of oxygenator or pump system used, which is an important 
limitation since the care of ECMO patients is not standardized across centers. Moreover, 
factors leading to the decision to use HFV or CMV, the influence of severity of illness on the 
decision to use of a particular lung rest strategy, and non-pulmonary causes that may affect 
the decision for duration of mechanical ventilation after decannulation could not be 
assessed. Future studies addressing these factors may provide additional useful information. 
Finally, our data set does not contain information regarding inflammatory markers of lung 
injury or post decannulation lung function assessment. Future studies looking into 
inflammatory mediators during and after ECMO course and follow up assessment of 
pulmonary function would shed greater light on appropriate lung rest strategies.
CONCLUSIONS
Wide practice variation exists amongst practitioners with regard to lung rest ventilator 
strategies during neonatal respiratory ECMO. The use of HFV compared with CMV for lung 
rest during ECLS is associated with longer duration of ECMO and mechanical ventilation. 
The use of a higher PEEP strategy compared with lower PEEP strategy is associated with 
shorter ECMO duration and modest increase duration of mechanical ventilation following 
decannulation in survivors. Reasons for these associations remain to be elucidated through 
carefully designed prospective trials.
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Figure 1. 
Complications – CMV vs. HFV. Percentage of patients in CMV and HFV groups with CNS 
and pulmonary complications. *P<0.05
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Figure 2. 
Complications – Low PEEP vs. High PEEP. Percentage of patients in low PEEP and high 
PEEP groups with CNS and pulmonary complications
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Table 1
Frequently used conventional mechanical ventilator setting for lung rest at 24 hours after extracorporeal 
membrane oxygenation initiation for neonatal respiratory failure
Rate
N = 2,630
PIP cm H2O
N = 2,548
PEEP cm H2O
N = 2,659
FiO2
N = 2,667
3rd–99th percentile 8–46 14–33 4–14 21–100
Most commonly used setting (% frequency) 10 (45.3) 15–20 (55.1) 10–12 (42.9) 0.40 (27.3)
2nd most commonly used setting (% frequency) 20 (20.1) 21–25 (26.7) 4–6 (31.6) 0.30 (26.8)
3rd most commonly used setting (% frequency) 30 (5.9) 26–30 (8.9) 7–9 (21.5) 0.21 (24.6)
Peak inspiratory pressure (PIP); positive end expiratory pressure (PEEP); fraction of inspired oxygen (FiO2)
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Table 2
High frequency ventilation vs. conventional mechanical ventilation for lung rest–demographics and clinical 
characteristics
Characteristic Data AvailableN (%)
Overall
N = 3040
HFV
N = 363
CMV
N = 2677
Gestational age (weeks) 2783 (91.5) 39 (38, 40) 39 (38, 40) 39 (38, 40)
Birth weight (kg) 2783 (91.5) 3.3 (2.9, 3.7) 3.34 (3, 3.8) 3.3 (2.9, 3.7)
Female gender (%) 3021 (99.4) 1299 (43) 171 (47) 1128 (42)
APGAR < 5 at 5 min (%) 2666 (87.7) 492 (18.5) 56 (18) 436 (18)
Day of life at time of ECMO initiation 3040 (100) 2 (1, 3) 2 (1, 3) 2 (1, 3)
Hours of mechanical ventilation prior to ECMO 2913 (95.8) 33 (17, 62.5) 34 (18, 63) 33 (17, 62)
CMV ventilator type pre-ECMO (%) 2796 (92) 929 (30.6) 15 (4.4) 914 (37)a
pH 2978 (98) 7.21 (7.1, 7.31) 7.18 (7.07, 7.29) 7.22 (7.1, 7.32)a
RSS (MAP * FiO2) 2441 (80) 18 (15, 22) 20 (17, 23) 18 (15, 21)a
Oxygenation index 2409 (79) 48 (34, 68) 54 (39, 77) 47 (33, 67)a
MBP prior to ECMO (mmHg) 1995 (65.6) 43 (36, 52) 40 (34, 49) 44 (36, 52)a
Pump flow at 24h on ECMO (ml/kg/min) 2853 (93.8) 107 (95, 125) 106 (95, 125) 107 (95, 126)
VV ECMO (%) 3024 (99.5) 1204 (39.8) 130 (36) 1074 (40)a
Data presented as median (interquartile ranges) or number (percentage);
a
P < 0.05
High frequency ventilation (HFV); conventional mechanical ventilation (CMV); extracorporeal membrane oxygenation (ECMO); respiratory 
severity score (RSS); mean airway pressure (MAP); fraction of inspired oxygen (FiO2); mean arterial blood pressure (MBP); venovenous (VV)
Pediatr Crit Care Med. Author manuscript; available in PMC 2018 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Alapati et al. Page 14
Ta
bl
e 
3
H
ig
h 
fre
qu
en
cy
 v
en
til
at
io
n 
vs
. c
on
v
en
tio
na
l m
ec
ha
ni
ca
l v
en
til
at
io
n 
fo
r l
un
g 
re
st–
du
ra
tio
n 
of
 ex
tr
ac
or
po
re
al
 m
em
br
an
e 
ox
yg
en
at
io
n 
an
d 
m
ec
ha
ni
ca
l 
v
en
til
at
io
n 
af
te
r d
ec
an
nu
la
tio
n 
in
 su
rv
iv
o
rs
C
ha
ra
ct
er
ist
ic
D
at
a 
Av
a
ila
bl
e
N
 (%
)
O
ve
ra
ll
N
 =
 2
35
4
H
FV
N
 =
 2
59
C
M
V
N
 =
 2
09
5
A
dju
ste
d O
dd
s R
ati
o
(95
%
 C
I)
EC
M
O
 h
ou
rs
 in
 su
rv
iv
o
rs
 [m
ed
ian
 (I
QR
)]
23
28
 (9
8.9
)
12
8 
(93
, 1
83
)
15
0.
5 
(11
1, 
22
2)
12
6 
(92
, 1
78
)
1.
52
 (1
.02
, 2
.3)
a
A
dju
ste
d E
CM
O 
ho
urs
 in
 su
rvi
v
o
rs
 (m
ea
n ±
 SE
M
)
15
0.
2 
± 
0.
05
12
5 
± 
0.
02
 b
H
ou
rs
 o
f m
ec
ha
ni
ca
l v
en
til
at
io
n 
af
te
r d
ec
an
nu
la
tio
n 
in
 su
rv
iv
o
rs
 [m
ed
ian
 (I
QR
)]
18
41
 (7
8.2
)
10
6 
(56
, 1
89
)
13
4 
(84
, 2
42
)
10
0 
(52
, 1
78
)
1.
9 
(1.
2, 
2.9
)a
A
dju
ste
d d
ura
tio
n o
f m
ech
an
ica
l v
en
til
at
io
n 
af
te
r d
ec
an
nu
la
tio
n 
in
 su
rv
iv
o
rs
 (m
ea
n ±
 SE
M
)
13
5 
± 
0.
09
10
0.
2 
± 
0.
03
b
a P
 
<
 0
.0
5
b P
 
<
 0
.0
1
Th
e 
va
ria
bl
es
 in
cl
ud
ed
 in
 th
e 
m
od
el
: g
es
ta
tio
na
l a
ge
, b
irt
h 
w
ei
gh
t, 
ag
e 
at
 ti
m
e 
of
 in
iti
at
io
n 
of
 E
CM
O
, A
PG
A
R 
sc
or
e 
of
 le
ss
 th
an
 5
 at
 5
 m
in
ut
es
, d
ur
at
io
n 
of
 m
ec
ha
ni
ca
l v
en
til
at
io
n 
pr
io
r t
o 
EC
M
O
 in
iti
at
io
n,
 
R
SS
, O
I, 
pH
, M
BP
,
 
EC
M
O
 p
um
p 
flo
w
 a
t 2
4 
ho
ur
s a
fte
r E
CM
O
 in
iti
at
io
n,
 a
nd
 E
CM
O
 m
od
e.
H
FV
,
 
hi
gh
 fr
eq
ue
nc
y 
ve
n
til
at
io
n;
 C
M
V,
 
co
nv
en
tio
na
l m
ec
ha
ni
ca
l v
en
til
at
io
n;
 C
I, 
co
nf
id
en
ce
 in
te
rv
al
; E
CM
O
, e
x
tr
ac
or
po
re
al
 m
em
br
an
e 
ox
yg
en
at
io
n;
 IQ
R,
 in
ter
qu
art
ile
 ra
ng
e; 
SE
M
, s
tan
da
rd 
err
or 
of 
me
an
; 
R
SS
, r
es
pi
ra
to
ry
 se
v
er
ity
 sc
or
e;
 O
I, 
ox
yg
en
at
io
n 
in
de
x
Pediatr Crit Care Med. Author manuscript; available in PMC 2018 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Alapati et al. Page 15
Ta
bl
e 
4
Lo
w
 v
s.
 m
id
 v
s. 
hi
gh
 p
os
iti
v
e 
en
d 
ex
pi
ra
to
ry
 p
re
ss
ur
e 
fo
r l
un
g 
re
st–
de
m
og
ra
ph
ic
s a
nd
 c
lin
ic
al
 c
ha
ra
ct
er
ist
ic
s
C
ha
ra
ct
er
ist
ic
D
at
a 
Av
a
ila
bl
e
N
 (%
)
O
ve
ra
ll
N
=2
55
7
Lo
w
 P
EE
P
N
=8
41
M
id
 P
EE
P
N
=5
74
H
ig
h 
PE
EP
N
=1
14
2
G
es
ta
tio
na
l a
ge
 (w
ee
ks
)
23
76
 (9
3)
39
 (3
8, 
40
)
39
 (3
8, 
40
)
39
 (3
8, 
40
)
39
 (3
8, 
40
)
B
irt
h 
w
ei
gh
t (
kg
)
23
64
 (9
2)
3.
3 
(2.
9, 
3.7
)
3.
27
 (2
.9,
 3.
7)
3.
24
 (2
.9,
 3.
7)
3.
32
 (3
, 3
.7)
 a
Fe
m
al
e 
ge
nd
er
 (%
)
25
43
 (9
9)
10
82
 (4
2)
34
7 
(41
)
25
2 
(44
)
48
3 
(42
)
A
PG
A
R 
< 
5 
at
 5
 m
in
 (%
)
22
62
 (8
8)
41
5 
(18
)
13
0 
(17
)
82
 (1
6)
20
3 
(21
) a
D
ay
 o
f l
ife
 a
t t
im
e 
of
 E
CM
O
 in
iti
at
io
n
25
57
 (1
00
)
2 
(1,
 3)
2 
(1,
 3)
2 
(1,
 4)
2 
(1,
 3)
H
ou
rs
 o
f m
ec
ha
ni
ca
l v
en
til
at
io
n 
pr
io
r t
o 
EC
M
O
24
60
 (9
6)
33
 (1
7, 
62
)
33
 (1
6, 
61
)
34
 (1
7, 
70
)
33
 (1
7, 
59
)
CM
V
 v
en
til
at
or
 ty
pe
 p
re
-E
CM
O
 (%
)
23
48
 (9
2)
88
5 
(38
)
32
6 
(42
)
19
7 
(37
)
36
2 
(35
) a
pH
25
06
 (9
8)
7.
22
 (7
.1,
 7.
32
)
7.
23
 (7
.1,
 7.
33
)
7.
2 
(7.
09
, 7
.32
)
7.
22
 (7
.11
, 7
.31
)
R
SS
 (M
AP
 * 
FiO
2)
15
42
 (7
9)
18
 (1
4, 
21
)
17
 (1
4, 
20
)
18
 (1
5, 
20
)
18
 (1
5, 
22
)a
O
xy
ge
na
tio
n 
in
de
x
19
93
 (7
8)
46
 (3
3, 
66
)
44
.8
 (3
3, 
65
)
46
 (3
3, 
65
)
48
 (3
4, 
67
)
M
B
P 
pr
io
r t
o 
EC
M
O
 (m
mH
g)
17
06
 (6
7)
44
 (3
6, 
52
)
44
 (3
5, 
52
)
42
 (3
5, 
49
) a
44
 (3
8, 
53
)
Pu
m
p 
flo
w
 a
t 2
4h
 o
n 
EC
M
O
 (m
l/k
g/m
in)
25
38
 (9
9)
10
8 
(96
, 1
27
)
11
0 
(96
, 1
28
)
10
8 
(97
, 1
27
)
10
7 
(95
,12
9)
V
V
 E
CM
O
 (%
)
25
46
 (9
9)
10
32
 (4
0)
31
5 
(38
)
29
0 
(50
)a
42
7 
(38
)
M
or
ta
lit
y 
(%
)
25
57
 (1
00
)
53
9 
(21
)
17
2 
(20
)
12
2 
(21
)
24
5 
(21
)
D
at
a 
pr
es
en
te
d 
as
 m
ed
ia
n 
(in
ter
qu
art
ile
 ra
ng
es)
 or
 nu
mb
er 
(pe
rce
nta
ge
);
a P
 
<
 0
.0
5
PE
EP
,
 
po
sit
iv
e 
en
d 
ex
pi
ra
to
ry
 p
re
ss
ur
e;
 E
CM
O
, e
x
tr
ac
or
po
re
al
 m
em
br
an
e 
ox
yg
en
at
io
n;
 C
M
V,
 
co
nv
en
tio
na
l m
ec
ha
ni
ca
l v
en
til
at
io
n;
 R
SS
, r
es
pi
ra
to
ry
 se
v
er
ity
 sc
or
e;
 M
A
P,
 
m
ea
n
 a
rt
er
ia
l p
re
ss
ur
e;
 F
iO
2,
 
fra
ct
io
n 
of
 in
sp
ire
d 
ox
yg
en
; M
BP
,
 
m
ea
n
 a
rt
er
ia
l b
lo
od
 p
re
ss
ur
e;
 V
V,
 
v
en
o
v
en
o
u
s
Pediatr Crit Care Med. Author manuscript; available in PMC 2018 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Alapati et al. Page 16
Ta
bl
e 
5
Lo
w
 v
s.
 m
id
 v
s. 
hi
gh
 p
os
iti
v
e 
en
d 
ex
pi
ra
to
ry
 p
re
ss
ur
e 
fo
r l
un
g 
re
st–
du
ra
tio
n 
of
 ex
tr
ac
or
po
re
al
 m
em
br
an
e 
ox
yg
en
at
io
n 
an
d 
m
ec
ha
ni
ca
l v
en
til
at
io
n 
af
te
r 
de
ca
nn
ul
at
io
n 
in
 su
rv
iv
o
rs
C
ha
ra
ct
er
ist
ic
D
at
a 
Av
a
ila
bl
e
N
 (%
)
O
ve
ra
ll
N
 =
 2
01
8
Lo
w
 P
EE
P
N
 =
 6
69
M
id
 P
EE
P
N
 =
45
2
H
ig
h 
PE
EP
N
 =
 8
97
A
dju
ste
d O
dd
s R
ati
o 
(95
%
 C
I)
M
id
 P
EE
P 
vs
. L
ow
 
PE
EP
A
dju
ste
d O
dd
s r
ati
o 
(95
%
 C
I)
H
ig
h 
PE
EP
 v
s. 
Lo
w
 
PE
EP
EC
M
O
 h
ou
rs
 in
 su
rv
iv
o
rs
 [m
ed
ian
 (I
QR
)]
19
99
 (9
9.1
)
12
7 
(92
, 1
80
)
14
2 
(99
, 1
92
)
12
1 
(93
, 1
74
)
12
0 
(85
, 1
66
)
0.
61
 (0
.4,
 0.
9)a
0.
47
(0.
3, 
0.7
)c
A
dju
ste
d E
CM
O 
ho
urs
 in
 su
rvi
v
o
rs
 (m
ea
n ±
 
SE
M
)
15
6 
± 
1.
06
14
1 
± 
1.
06
13
6 
± 
1.
05
 b
H
ou
rs
 o
f m
ec
ha
ni
ca
l v
en
til
at
io
n 
af
te
r 
de
ca
nn
ul
at
io
n 
in
 su
rv
iv
o
rs
 [m
ed
ian
 (I
QR
)]
15
74
 (7
8)
10
1.
5 
(56
, 1
93
)
97
 (4
9, 
18
8.5
)
95
 (5
3, 
15
2)
11
5 
(67
.75
, 2
05
.25
)
0.
9 
(0.
7,1
.5)
1.
0 
(0.
7, 
1.5
)
A
dju
ste
d d
ura
tio
n o
f m
ech
an
ica
l v
en
til
at
io
n 
af
te
r d
ec
an
nu
la
tio
n 
in
 su
rv
iv
o
rs
 (m
ea
n ±
 SE
M
)
10
3 
± 
1.
12
10
5 
± 
1.
12
11
4 
± 
1.
11
a P
 
<
 0
.0
5
b P
 
<
 0
.0
1
c P
 
<
 0
.0
01
Th
e 
va
ria
bl
es
 in
cl
ud
ed
 in
 th
e 
m
od
el
: g
es
ta
tio
na
l a
ge
, b
irt
h 
w
ei
gh
t, 
ag
e 
at
 ti
m
e 
of
 in
iti
at
io
n 
of
 E
CM
O
, A
PG
A
R 
sc
or
e 
of
 le
ss
 th
an
 5
 at
 5
 m
in
ut
es
, d
ur
at
io
n 
of
 m
ec
ha
ni
ca
l v
en
til
at
io
n 
pr
io
r t
o 
EC
M
O
 in
iti
at
io
n,
 
R
SS
, O
I, 
pH
, M
BP
,
 
EC
M
O
 p
um
p 
flo
w
 a
t 2
4 
ho
ur
s a
fte
r E
CM
O
 in
iti
at
io
n,
 a
nd
 E
CM
O
 m
od
e.
 P
EE
P,
 
po
sit
iv
e 
en
d 
ex
pi
ra
to
ry
 p
re
ss
ur
e;
 C
I, 
co
nf
id
en
ce
 in
te
rv
al
; E
CM
O
, e
x
tr
ac
or
po
re
al
 m
em
br
an
e 
ox
yg
en
at
io
n;
 
IQ
R,
 in
ter
qu
art
ile
 ra
ng
e; 
SE
M
, s
tan
da
rd 
err
or 
of 
me
an
; R
SS
, re
sp
ira
tor
y s
ev
er
ity
 in
de
x
; O
I, 
ox
yg
en
at
io
n 
in
de
x
; M
B
P,
 
m
ea
n
 a
rt
er
ia
l b
lo
od
 p
re
ss
ur
e
Pediatr Crit Care Med. Author manuscript; available in PMC 2018 July 01.
